Answers are grounded in this paper and cite their sources.
Fluid biomarkers such as CSF and plasma p-tau isoforms, MTBR-tau243, and their correlations with tau PET imaging provide valuable, albeit imperfect, tools in the diagnosis and management of tauopathies. Improved biomarker specificity and validation across tauopathy spectra remain crucial.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: